Renagel (Genzyme Corporation)
Welcome to the PulseAid listing for the Renagel drug offered from Genzyme Corporation. This Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Genzyme Corporation |
| NON-PROPRIETARY NAME: | Renagel |
| SUBSTANCE NAME: | SEVELAMER HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2008-06-06 |
| END MARKETING DATE: | 0000-00-00 |
Renagel HUMAN PRESCRIPTION DRUG Details:
| Item Description | Renagel from Genzyme Corporation |
| LABELER NAME: | Genzyme Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400(mg/1) |
| START MARKETING DATE: | 2008-06-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 58468-0020_4181ad6d-70e4-4682-bda7-4921da949aa8 |
| PRODUCT NDC: | 58468-0020 |
| APPLICATION NUMBER: | NDA021179 |
Other SEVELAMER HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
